Psychiatry and Neurology, Neurology · Tallahassee, FL
NPI
1134196215
Since 2006
Specialty
Psychiatry and Neurology, Neurology
Code 2084N0400X
Group practices
1
Medicare group memberships
Hospitals
2
Hospital affiliations
1401 Centerville Rd Ste 600
Tallahassee, FL, 32308
Phone (850) 878-8121
Groups this clinician bills Medicare through
Medicare paid, 2024
$173K
22,630 services
Medicare patients, 2024
237
Average age 70
Drug cost, 2024
$3.0M
6,992 prescriptions
Company payments, 2025
$4,378
From 29 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Winston R Ortiz was code J0585 (injection, onabotulinumtoxina, 1 unit), 21,695 times for 41 patients. In total Winston R Ortiz billed 22,630 services in 24 codes, and Medicare paid $173K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2022-07-21.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J0585 Injection, onabotulinumtoxina, 1 unit | Office | 21,695 | 41 | $4.82 | $105K |
| 95886 Electrical Nerve Conductivity | Office | 158 | 98 | $73.72 | $12K |
| 99213 Office E&M - Established | Office | 135 | 86 | $65.17 | $8,797 |
| 95874 Musculoskeletal | Office | 75 | 31 | $54.40 | $4,080 |
| 95911 Electrical Nerve Conductivity | Office | 59 | 59 | $158.63 | $9,359 |
| 64615 Musculoskeletal | Office | 45 | 17 | $121.73 | $5,478 |
| 99212 Office E&M - Established | Office | 41 | 41 | $43.89 | $1,800 |
| 95910 Electrical Nerve Conductivity | Office | 36 | 36 | $135.41 | $4,875 |
| 64616 Musculoskeletal | Office | 34 | 12 | $151.38 | $5,147 |
| 64644 Musculoskeletal | Office | 32 | 17 | $118.94 | $3,806 |
| 99204 Office E&M - New | Office | 31 | 31 | $132.12 | $4,096 |
By year: 2022 $168K for 21,590 services; 2023 $180K for 23,447 services; 2024 $173K for 22,630 services.
Medicare prescription drug claims, 2024
In 2024, the drug Winston R Ortiz prescribed most often to Medicare patients was Gabapentin, with 517 prescriptions and refills. In total Winston R Ortiz wrote 6,992 Medicare prescriptions that cost $3.0M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Gabapentin Generic | 517 | 857 | 157 | $13K |
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | 459 | 459 | 64 | $13K |
| Pregabalin Generic | 332 | 410 | 78 | $8,989 |
| Clonazepam Generic | 306 | 340 | 56 | $3,284 |
| Oxycodone-Acetaminophen Oxycodone Hcl/Acetaminophen | 302 | 303 | 36 | $10K |
| Tramadol Hcl Generic | 254 | 255 | 63 | $2,929 |
| Donepezil Hcl Generic | 207 | 481 | 81 | $3,198 |
| Levetiracetam Generic | 188 | 333 | 43 | $8,482 |
| Memantine Hcl Generic | 184 | 363 | 71 | $5,190 |
| Baclofen Generic | 183 | 349 | 60 | $8,223 |
| Zolpidem Tartrate Generic | 168 | 170 | 20 | $1,139 |
| Topiramate Generic | 164 | 320 | 43 | $2,063 |
| Alprazolam Generic | 154 | 154 | 22 | $1,268 |
| Lacosamide Generic | 148 | 184 | 34 | $17K |
| Butalbital-Acetaminophen-Caffe Butalb/Acetaminophen/Caffeine | 147 | 147 | 38 | $13K |
Brand drugs: 774 claims; generic drugs: 6,173 claims; opioid claims: 1,286.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Winston R Ortiz $4,378 ($4,378 in general payments such as food, travel and fees) from 29 companies. The largest payer was TG Therapeutics, Inc. with $749.
| Company | Payments | Amount |
|---|---|---|
| TG Therapeutics, Inc. TGTX | 13 | $749 |
| Pfizer Inc. PFE | 21 | $424 |
| UCB, Inc. UCB.BR | 17 | $326 |
| Alexion Pharmaceuticals, Inc. AZN | 6 | $317 |
| Biogen, Inc. BIIB | 10 | $291 |
| Amgen Inc. AMGN | 9 | $280 |
| Teva Pharmaceuticals USA, Inc. TEVA | 9 | $227 |
| Abbvie Inc. ABBV | 15 | $199 |
| Novartis Pharmaceuticals Corporation NVS | 9 | $199 |
| Eisai Inc. 4523.T | 4 | $184 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.